[Is atrial fibrillation an independent marker of cardiovascular risk?]

G Moubarak1, A Messali, F Extramiana

  • 1Service de Cardiologie, Centre de Référence Maladies Cardiaques Héréditaires, Université Paris 7, Hôpital Lariboisière, France. antoine.leenhardt@lrb.aphp.fr

Annales De Cardiologie Et D'Angeiologie
|January 8, 2011
PubMed

Insights

Atrial fibrillation (AF) is common in older adults. While lone AF may not increase mortality risk, AF with comorbidities negatively impacts survival and morbidity.

Area of Science:

  • Cardiology
  • Geriatric Medicine

Context:

  • Atrial fibrillation (AF) is the most common cardiac arrhythmia, with prevalence increasing with age.
  • AF is associated with stroke and heart failure, but its direct impact on mortality is debated.
  • Distinguishing AF's independent effect from comorbidities is challenging.

Purpose:

  • To clarify the relationship between atrial fibrillation and mortality.
  • To assess the impact of lone AF versus AF with comorbidities on patient outcomes.
  • To review current and potential future therapeutic strategies for AF management.

Summary:

  • Lone AF, without underlying heart disease, appears not to be an independent predictor of mortality.
  • In patients with comorbidities like hypertension or heart failure, AF significantly worsens survival and morbidity.
  • Current antiarrhythmic drugs have not demonstrated mortality benefits in AF patients.

Impact:

  • Highlights the critical role of comorbidities in AF-related outcomes.
  • Suggests that managing associated conditions is key to improving prognosis in AF patients.
  • Points to novel treatments like new antiarrhythmic agents and catheter ablation as promising for reducing AF burden and improving patient survival.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...